Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
13.17 USD 0.00(0%)
Last update at 2026-11-18T21:00:00Z
VOLUME
100
Market Cap
2198.72M
P/E
16.37

Momentum Score

…

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
13.17
Low
14.78
High
52 Week Price Range
8.74
Low
16.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Azelis Group NV is a distributor of specialty chemicals and food ingredients providing formulation, technical sales and sourcing to industrial and consumer end markets worldwide. Long-term growth may be supported by demand for specialty and sustainable formulations, expansion into higher-growth end markets and geographic and acquisition-led diversification, and investors may view its technical sales model and wide supplier network as strengths.

Key risks include margin pressure and supplier concentration, execution and integration risk from acquisitions, cyclicality of end markets and exposure to currency and commodity volatility and regulatory compliance costs.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
13.17
Dividend Yield
2.26%
Revenue TTM
4110.78M
Revenue Per Share
16.88
Gross Profit TTM
946.75M
Debt / Equity
0.75
ROE
4.03%
Net Debt
1744.26M
ROCE
6.21%
Diluted EPS TTM
0.54

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 175.16M 256.11M 247.24M 314.67M 120.20M
Minority interest -2.21M -8.78M -11.61M -5.69M -2.47M
Net income 111.15M 180.69M 177.70M 213.19M 67.76M
Selling general administrative 172.51M 79.94M 80.24M 70.96M 85.46M
Selling and marketing expenses - 95.03M 86.53M 87.80M 62.49M
Gross profit 499.73M 1031.05M 960.67M 960.74M 641.67M
Reconciled depreciation 127.21M 114.92M 101.10M 84.73M 59.38M
Ebit 291.51M 362.08M 344.61M 348.51M 170.10M
Ebitda 418.67M 477.01M 445.70M 433.24M 229.48M
Depreciation and amortization 127.16M 114.92M 101.10M 84.73M 59.38M
Operating income 291.51M 385.93M 386.90M 388.43M 207.81M
Other operating expenses 3817.73M 3852.04M 3765.32M 3736.47M 2619.48M
Interest expense 124.00M 144.29M 97.37M 38.22M 49.90M
Tax provision 61.82M 66.64M 57.93M 95.79M 49.97M
Interest income 5.12M 14.82M 10.69M 0.62M 0.62M
Net interest income -118.34M -123.46M -132.01M -76.10M -86.31M
Income tax expense 61.80M 66.64M 57.93M 95.79M 49.97M
Total revenue 4109.24M 4237.97M 4152.23M 4124.90M 2827.30M
Total operating expenses 208.22M 645.12M 573.77M 572.32M 433.86M
Cost of revenue 3609.51M 3206.92M 3191.55M 3164.16M 2185.62M
Total other income expense net -116.35M -129.82M -139.66M -73.76M -87.61M
Net income from continuing ops 113.41M 189.47M 189.31M 218.88M 70.22M
Net income applicable to common shares - - - 213.19M 67.76M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5404.65M 5762.88M 5572.23M 4976.73M 3981.80M
Intangible assets 1285.52M 1391.78M 1345.42M 1170.49M 1004.26M
Other current assets - 11.38M 100.91M -0.00M 1.52M
Total liab 2689.94M 2842.73M 2895.65M 2537.05M 1730.46M
Total stockholder equity 2693.57M 2876.14M 2590.00M 2384.53M 2227.55M
Deferred long term liab - - - - 3.54M
Other current liab 17.11M 204.05M 356.02M 336.49M 191.44M
Common stock 5877.80M 5880.00M 5880.00M 5680.00M 5680.00M
Capital stock 5880.00M 5880.00M 5880.00M 5680.00M 5680.00M
Retained earnings 989.43M 876.33M 637.08M 405.76M 164.57M
Other liab - - - 302.14M 157.92M
Good will 2471.30M 2536.84M 2409.25M 2174.26M 1803.27M
Other assets - - - 32.36M 15.38M
Cash 262.91M 303.94M 484.87M 268.16M 141.29M
Total current liabilities 709.52M 818.87M 939.75M 975.35M 678.43M
Net debt 1744.26M 1540.05M 1291.22M 1167.53M 871.14M
Short term debt 137.17M 95.60M 125.12M 176.12M 118.33M
Short long term debt 108.85M 66.32M 98.85M 155.74M 103.13M
Short long term debt total 2007.17M 1843.99M 1776.10M 1435.69M 1012.44M
Other stockholder equity -4173.67M -3880.19M -7854.15M -3701.23M -3617.02M
Property plant equipment - - - 154.87M 118.59M
Total current assets 1386.02M 1582.90M 1593.49M 1444.52M 1043.67M
Net tangible assets - - - -960.21M -576.43M
Short term investments 0.00M 0.60M 0.06M 0.28M 1.52M
Net receivables 535.13M 589.03M 444.86M 548.34M 433.38M
Long term debt 1602.49M 1613.92M 1550.63M 1178.39M 840.03M
Inventory 587.97M 677.95M 562.79M 627.74M 467.47M
Accounts payable 555.24M 486.80M 434.08M 462.73M 368.66M
Accumulated other comprehensive income - - -3927.08M - -
Non currrent assets other 0.00M 0.60M 27.16M 0.28M 3.04M
Non current assets total 4018.63M 4179.98M 3978.74M 3532.21M 2938.13M
Capital lease obligations 162.47M 163.75M 126.62M 101.56M 69.28M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -255.33M -600.05M -572.11M -652.17M
Change to liabilities - - - 22.34M 80.39M
Total cashflows from investing activities -257.35M -255.33M -600.05M -572.11M -652.17M
Net borrowings 22.01M 44.35M 314.77M 400.45M -338.95M
Total cash from financing activities -68.88M -246.99M 304.92M 341.04M 523.83M
Change to operating activities - - - 1.14M -1.23M
Net income 111.15M 189.47M 189.31M 218.88M 70.22M
Change in cash -4.89M -181.79M 228.84M 136.98M -38.93M
Begin period cash flow 267.80M 466.59M 237.75M 100.77M 139.70M
End period cash flow 262.91M 284.80M 466.59M 237.75M 100.77M
Total cash from operating activities 310.83M 322.94M 525.10M 368.59M 89.90M
Issuance of capital stock - 0.00M 200.00M 0.00M 930.00M
Depreciation 127.16M 114.92M 101.10M 84.73M 59.38M
Dividends paid 54.89M 53.31M 67.77M 7.01M 7.01M
Change to inventory 66.02M -98.11M 123.60M -65.75M -101.37M
Change to account receivables - -55.17M 77.76M 27.19M -47.90M
Sale purchase of stock -1.14M -2.51M -3.41M -3.00M -
Other cashflows from financing activities -34.85M -235.52M -138.67M 568.43M 825.17M
Change to netincome - - - 85.75M 1.55M
Capital expenditures 24.90M 13.88M 15.48M 18.44M 18.29M
Change in working capital 48.98M -132.90M 128.20M -15.08M -70.11M
Stock based compensation 1.80M 1.28M 1.37M 0.84M -
Other non cash items 23.54M 150.17M 139.76M 79.22M 30.39M
Free cash flow 285.93M 309.06M 509.61M 350.15M 71.61M

Peer Comparison*

Sector: Basic Materials Industry: Specialty Chemicals

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AZLGF
Azelis Group NV
-
-%
13.17 16.37 12.90 0.53 0.77 1.00 10.33
LIN
Linde plc Ordinary Shares
-1.95
0.38%
510.21 33.77 28.90 6.56 5.42 7.03 18.92
AIQUY
Air Liquide SA ADR
-0.21
0.50%
41.40 30.69 24.81 4.70 4.10 4.36 15.61
AIQUF
L'Air Liquide S.A
-
-%
208.06 29.78 22.68 4.54 3.98 4.50 15.90
SHW
Sherwin-Williams Co
-6.77
1.95%
339.83 33.33 27.40 3.38 20.60 3.88 21.36

Profile*

Azelis Group NV

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Posthofbrug 12, Antwerp, Belgium, 2600

32 3 613 01 20

3998

Name Title Year Born
Dr. Hans-Joachim Müller Group CEO & Exec. Director 1959
Mr. Thijs Bakker CFO & Exec. Director 1974
Mr. Gerrit De Vos Group Gen. Counsel, Chief Compliance Officer & Company Sec. NA
Mr. Frank P. Bergonzi CEO & Pres of Americas 1961
Ms. Anna Bertona CEO & Pres of EMEA 1967
Mr. Laurent Nataf Chief Mergers & Acquisitions (M&A) Officer 1975
Mr. Sertac Surur CEO & Pres for Asia Pacific NA
Ms. Pamela Antay Sr. VP of Equity & Credit Relations NA
Mr. Thijs Bakker CFO & Executive Director 1975
Ms. Anna Bertona Chief Executive Officer 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…